DUBLIN--(BUSINESS WIRE)--The "Pet Veterinary Drugs Market" report has been added to ResearchAndMarkets.com's offering.
The global Pet Veterinary Drugs Market reached USD 16,239.3 Million in 2018. Moreover, the market is expected to garner USD 21,205.2 Million by the end of 2025 by registering a CAGR of 3.9% across the globe. The global demand for Pet Veterinary Drugs is increasing due to significant growth in healthcare industry across the globe. Further, growing pet adoption and increase in pet expenditure and routine care are key growth driver for global pet veterinary drugs market over the forecast period.
North America is slated to account for a share of 38.5% by 2025 in the pet veterinary drugs market. The growth in the region can be attributed to growing pet expenditure. Re-occurrence of animal diseases is also expected to impel the growth of pet veterinary drugs market in the North America. U.S. is the prominent market driving the growth in the region. Additionally, U.S. pet veterinary drugs market reached USD 5,427 Million in 2018 and is expected to reach USD7,176.2 Million by the end of 2025, expanding at a CAGR of 4.1% over the forecast period i.e. 2019-2025. U.S. pet veterinary drugs market is expected to achieve Y-o-Y growth rate of 4.4% in 2025 as compared to previous year.
The global pet veterinary drugs market is segmented on the basis of drugs into Pharmaceuticals & Biologics and Vaccines. Among these segments, Pharmaceuticals & Biologics segment (71.4% share in 2018) occupies the largest market of pet veterinary drugs across the globe. Further, vaccines segment is anticipated to reach USD6,120.4 Million by the end of 2025 from USD4,643.1 Million in 2018. Moreover, this segment is anticipated to flourish at a CAGR of 4.1% over the forecast period. In addition Recombinant Vaccines segment of drugs is expected to achieve Y-o-Y growth rate of 4.6% in 2025 as compared to previous year.
The global pet veterinary drugs market is segmented on the basis of composition into Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics & Sedatives and Others. Among these segments, Parasiticides segment (42.4% share in 2018) occupies the largest market of pet veterinary drugs on the basis of composition across the globe. Further, global Anti-Infectives segment is anticipated to reach USD6,791.0 Million by the end of 2025 from USD 5,179.8 Million in 2018. Moreover, this segment is anticipated to flourish at a CAGR of 4.0% over the forecast period. In addition Parasiticides segment of pet veterinary drugs under composition is expected to achieve Y-o-Y growth rate of 4.4% in 2025 as compared to previous year.
Some of the leading manufacturers in this market are Zoetis, Bayer AG, Boehringer Ingelheim International GmbH, Merck Animal Health among others.
Key Topics Covered
1. Introduction
1.1. Market Definition
1.2. Product Overview
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Research Methodology
4. Executive Summary- Global Pet Veterinary Drugs Market
5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Trends
5.4. Opportunities
6. Risk Analysis
6.1. Demand Risk
6.2. Supply Risk
7. Global Pet Veterinary Drugs Market Outlook
7.1. Market Size and Forecast, 2016-2025
7.1.1. By Value (USD Million)
7.1.1.1. Y-o-Y Growth (%), 2017-2025
7.2. Market Share and Forecast, 2016-2025
7.2.1. By Drugs
7.2.1.1.a. Pet Veterinary Drugs Market Share (%), By Drugs (2016, 2025F)
7.2.1.1.1. Pharmaceuticals & Biologics, Vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.1.1.1.1. Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines & Toxoid vaccines, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.1.1.b. Pet Veterinary Drugs Market Analysis, By Drugs (2016, 2025F)
7.2.1.2. Market Attractiveness Analysis, By Drugs
7.2.1.3. Market Contribution and BPS Analysis, 2016 & 2025, By Drugs
7.2.2. By Composition
7.2.2.1.2.a. Pet Veterinary Drugs Market Share (%), By Composition (2016, 2025F)
7.2.2.1.1. Anti-Infectives, Anti-Inflammatory & Parasiticides, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.2.1.2. Analgesics & Sedatives and Others, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.2.1.b. Pet Veterinary Drugs Market Analysis, By Composition (2016, 2025F)
7.2.2.2. Market Attractiveness Analysis, By Composition
7.2.2.3. Market Contribution and BPS Analysis, 2016 & 2025, By Composition
7.2.3. By Route of Administration
7.2.3.1.a. Pet Veterinary Drugs Market Share (%), By Route of Administration (2016, 2025F)
7.2.3.1.1. Oral, Parenteral & Topical, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.3.1.b. Pet Veterinary Drugs Market Analysis, By Route of Administration (2016, 2025F)
7.2.3.2. Market Attractiveness Analysis, By Route of Administration
7.2.3.3. Market Contribution and BPS Analysis, 2016 & 2025, By Route of Administration
7.2.4. By End User
7.2.4.1.a. Pet Veterinary Drugs Market Share (%), By End User (2016, 2025F)
7.2.4.1.1. Veterinary Hospitals, Veterinary Clinics & Drug Stores, 2016-2025F (USD Million) & Y-o-Y Growth (%), 2017-2025
7.2.4.1.b. Pet Veterinary Drugs Market Analysis, By End User (2016, 2025F)
7.2.4.2. Market Attractiveness Analysis, By End User
7.2.4.3. Market Contribution and BPS Analysis, 2016 & 2025, By End User
7.2.5. By Region
7.2.5.1. Pet Veterinary Drugs Market Share (%), By Region (2016,2025F)
7.2.5.1.1. North America
7.2.5.1.2. Europe
7.2.5.1.3. Asia Pacific
7.2.5.1.4. Latin America
7.2.5.1.5. Middle East and Africa
8. North America Pet Veterinary Drugs Market Outlook
9. Europe Pet Veterinary Drugs Market Outlook
10. Asia Pacific Pet Veterinary Drugs Market Outlook
11. Latin America Pet Veterinary Drugs Market Outlook
12. Middle East & Africa Pet Veterinary Drugs Market Outlook
13. Policies & Regulations
14. Porter's Five Force Model
15. Competitive Landscape
15.1. Competitive Positioning of Major Players in Global Pet Veterinary Drugs Market
15.2. Company Profiles
15.2.1. Boehringer Ingelheim International GmbH
15.2.1.1. Company Overview
15.2.1.2. Business Strategy
15.2.1.2.1. Growth Expansion Strategy
15.2.1.2.2. Distribution Channel Strategy
15.2.1.2.3. Product Strategy
15.2.1.3. Key Product Offerings
15.2.1.4. Financial Performance
15.2.1.5. Key Performance Indicators
15.2.1.6. Risk Analysis
15.2.1.7. Recent Development
15.2.1.8. Regional Presence
15.2.1.9. SWOT Analysis
15.2.2. Zoetis Animal Healthcare
15.2.3. Bayer AG
15.2.4. Merck Animal Health
15.2.5. Elanco Animal Health Inc.
15.2.6. Virbac Group
15.2.7. Ceva
15.2.8. Dechra Pharmaceuticals plc
15.2.9. Vetoquinol
15.2.10. Orion Corporation
15.2.11. Other Prominent Players
For more information about this report visit https://www.researchandmarkets.com/r/b8pbso
